The Role of Cardiac Microenvironment in Cardiovascular Diseases: Implications for Therapy

Overview

Journal Hum Cell

Publisher Springer

Specialty Cell Biology

Date 2024 Mar 18

PMID 38498133

Authors

Jiayu Yao

Yuejun Chen

Yuqing Huang

Xiaoou Sun

Xingjuan Shi

Affiliations

Soon will be listed here.

Abstract

Due to aging populations and changes in lifestyle, cardiovascular diseases including cardiomyopathy, hypertension, and atherosclerosis, are the leading causes of death worldwide. The heart is a complicated organ composed of multicellular types, including cardiomyocytes, fibroblasts, endothelial cells, vascular smooth muscle cells, and immune cells. Cellular specialization and complex interplay between different cell types are crucial for the cardiac tissue homeostasis and coordinated function of the heart. Mounting studies have demonstrated that dysfunctional cells and disordered cardiac microenvironment are closely associated with the pathogenesis of various cardiovascular diseases. In this paper, we discuss the composition and the homeostasis of cardiac tissues, and focus on the role of cardiac environment and underlying molecular mechanisms in various cardiovascular diseases. Besides, we elucidate the novel treatment for cardiovascular diseases, including stem cell therapy and targeted therapy. Clarification of these issues may provide novel insights into the prevention and potential targets for cardiovascular diseases.

Citing Articles

Amniotic membrane, a novel bioscaffold in cardiac diseases: from mechanism to applications.

Rayat Pisheh H, Darvishi A, Masoomkhah S Front Bioeng Biotechnol. 2025; 12:1521462.

PMID: 39758951 PMC: 11696288. DOI: 10.3389/fbioe.2024.1521462.

Gastrodin prevents myocardial injury in sleep-deprived mice by suppressing ferroptosis through SIRT6.

Wu Y, Miao Y, Cao Y, Gong Z Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):9111-9121.

PMID: 38896272 DOI: 10.1007/s00210-024-03230-4.

References

Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L . Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982-3021. PMC: 7755038. DOI: 10.1016/j.jacc.2020.11.010. View

Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W . Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394(10204):1145-1158. PMC: 6891889. DOI: 10.1016/S0140-6736(19)30427-1. View

Takeda N, Manabe I . Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling. Int J Inflam. 2011; 2011:535241. PMC: 3175723. DOI: 10.4061/2011/535241. View

Aggarwal M, Aggarwal B, Rao J . Integrative Medicine for Cardiovascular Disease and Prevention. Med Clin North Am. 2017; 101(5):895-923. DOI: 10.1016/j.mcna.2017.04.007. View

Mishra S, Chatterjee S . Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes. Glycobiology. 2014; 24(6):518-31. PMC: 4001711. DOI: 10.1093/glycob/cwu020. View

Liu T, Wen H, Li H, Xu H, Xiao N, Liu R . Oleic Acid Attenuates Ang II (Angiotensin II)-Induced Cardiac Remodeling by Inhibiting FGF23 (Fibroblast Growth Factor 23) Expression in Mice. Hypertension. 2020; 75(3):680-692. DOI: 10.1161/HYPERTENSIONAHA.119.14167. View

Gruver C, DeMayo F, Goldstein M, Means A . Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology. 1993; 133(1):376-88. DOI: 10.1210/endo.133.1.8319584. View

Laflamme M, Murry C . Heart regeneration. Nature. 2011; 473(7347):326-35. PMC: 4091722. DOI: 10.1038/nature10147. View

Hirose K, Payumo A, Cutie S, Hoang A, Zhang H, Guyot R . Evidence for hormonal control of heart regenerative capacity during endothermy acquisition. Science. 2019; 364(6436):184-188. PMC: 6541389. DOI: 10.1126/science.aar2038. View

10.

Liu S, Tang L, Zhao X, Nguyen B, Heallen T, Li M . Yap Promotes Noncanonical Wnt Signals From Cardiomyocytes for Heart Regeneration. Circ Res. 2021; 129(8):782-797. PMC: 8513110. DOI: 10.1161/CIRCRESAHA.121.318966. View

11.

Frias M, Pedretti S, Hacking D, Somers S, Lacerda L, Opie L . HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity. Atherosclerosis. 2013; 228(1):110-6. DOI: 10.1016/j.atherosclerosis.2013.02.003. View

12.

Shende P, Xu L, Morandi C, Pentassuglia L, Heim P, Lebboukh S . Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy. Cardiovasc Res. 2015; 109(1):103-14. DOI: 10.1093/cvr/cvv252. View

13.

Camelliti P, Borg T, Kohl P . Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res. 2004; 65(1):40-51. DOI: 10.1016/j.cardiores.2004.08.020. View

14.

Tallquist M . Cardiac Fibroblast Diversity. Annu Rev Physiol. 2020; 82:63-78. PMC: 10939057. DOI: 10.1146/annurev-physiol-021119-034527. View

15.

Yokota T, McCourt J, Ma F, Ren S, Li S, Kim T . Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury. Cell. 2020; 182(3):545-562.e23. PMC: 7415659. DOI: 10.1016/j.cell.2020.06.030. View

16.

Bonnans C, Chou J, Werb Z . Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014; 15(12):786-801. PMC: 4316204. DOI: 10.1038/nrm3904. View

17.

Ivey M, Kuwabara J, Riggsbee K, Tallquist M . Platelet-derived growth factor receptor-α is essential for cardiac fibroblast survival. Am J Physiol Heart Circ Physiol. 2019; 317(2):H330-H344. PMC: 6732481. DOI: 10.1152/ajpheart.00054.2019. View

18.

Jang S, Ihm S, Choo E, Kim O, Chang K, Park C . Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension. Hypertension. 2014; 63(6):1228-34. DOI: 10.1161/HYPERTENSIONAHA.113.01866. View

19.

Dobaczewski M, Chen W, Frangogiannis N . Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol. 2010; 51(4):600-6. PMC: 3072437. DOI: 10.1016/j.yjmcc.2010.10.033. View

20.

Nicin L, Wagner J, Luxan G, Dimmeler S . Fibroblast-mediated intercellular crosstalk in the healthy and diseased heart. FEBS Lett. 2021; 596(5):638-654. DOI: 10.1002/1873-3468.14234. View